Small cell lung cancer (SCLC) is deadly cancer with a high mortality rate in which most patients will relapse and die of this disease.¹ Despite an initial response rate of 80%, SCLC patients who fail the first-line treatment usually progress with a median time to progression of 3.5 months, with limited

Due to the co-existing prostate-specific antigen (PSA) raising and lowering factors, the commonly used PSA screening test often lacks sufficient sensitivity or specificity to accurately predict prostate cancer (PCa).¹ Spermine, a novel non-prostate massage urine biomarker, was recently shown to be

In the recent DREAMM-2 study, single-agent belantamab mafodotin-blmf has demonstrated anti-myeloma activity with a manageable safety profile in patients with relapsed or refractory multiple myeloma.¹ Based on this result, the United

In patients with pulmonary hypertension, an elevated pulmonary vascular resistance (PVR) of 3.0 Wood units (WU) or more has been known to be associated with poor clinical prognosis.¹ In a recent study published in The Lancet

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has given rise to the ongoing coronavirus disease 2019 (COVID-19) pandemic, is highly contagious and can lead to high morbidity and mortality rates.^1,2 A recent study published in Nature Medicine used data of host